The purpose of this trial is to evaluate 1) the dermatological tolerability of 2 facial sunscreens after 21 (+2) days of use under normal conditions on the half face by adult subjects with sensitive skin, 2) Compare the efficacy of investigational products (IPs) after 21 (+2) days of use in adult subjects with sensitive skin, under dermatological supervision through the following evaluations: the transepidermal water loss in the nasolabial region; the sensory perception of the subjects using the sensory perception questionnaire, after 21 (+2) days of use under normal conditions; the sensitivity of the subjects' skin after the first application of each product using a questionnaire on the perception of signs of discomfort.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change From Baseline in Dermatological Tolerability
Timeframe: Baseline (Day 1), Day 21
Change From Baseline in Skin Barrier Integrity
Timeframe: Baseline (Day 1), Day 21
Number of Participants With Sensory Perception as Assessed by Sensory Perception Questionnaire
Timeframe: At Day 21
Number of Participants With Skin Sensitivity as Assessed by Discomfort Questionnaire
Timeframe: At Day 1
Number of Participants With Adverse Events
Timeframe: Up to Day 21